GE Healthcare Acquires SeqWright | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GE Healthcare today announced it has purchased contract research organization SeqWright for an undisclosed amount.

The deal, GE said, is expected to complement its Clarient business, allowing the molecular diagnostics firm to expand its clinical diagnostics offerings to include next-generation sequencing.

Based in Houston, SeqWright was founded in 1984 and provides nucleic acid sequencing and other genomics services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.